We also heard from the Cancer Control Agency. This was our first review with the agency because they were only established in December 2019. Their role is to provide that national leadership in cancer care. Most of the agency's first year had been around operational issues, developing the operational model vision, and recruiting key staff. But we were also incredibly pleased to hear about the role they'd played during the COVID response the previous year, and in particular developing up some consistent guidelines, so that while some of our screening had not happened during level 3 and level 4, much of the treatment had gone on because of the guidelines that they developed, and that was incredibly positive.